Sichuan Kelun Pharmaceutical Co.,Ltd.’s Net Profit Rose 41.2% in First Three Quarters of 2021

Sichuan Kelun Pharmaceutical Co.,Ltd. (四川科伦药业股份有限公司) (002422.SZ) reported a net profit of 746.1 million yuan in the first three quarters of 2021, up 41.2% year-on-year.
Meanwhile, the company posted 12.7 billion yuan in revenue, up 8.8% year-on-year.
At the end of the reporting period, it had 31.8 billion yuan in total assets and 17.8 billion yuan in total liabilities, with a liability-to-asset ratio of 55.8%.
This article was automatically produced by Caixin Automation on Nov. 3, 2021.
Download our app to receive breaking news alerts and read the news on the go.
Follow the Chinese markets in real time with Caixin Global’s new stock database.
- PODCAST
- MOST POPULAR